申请人:Altman Michael D.
公开号:US20110245205A1
公开(公告)日:2011-10-06
The present invention provides novel pyrimidine amines of formula (I) which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis.
本发明提供了式(I)的新型嘧啶胺,它们是脾酪氨酸激酶的有效抑制剂,并且可用于治疗和预防由该酶介导的疾病,例如哮喘、COPD和类风湿性关节炎。